Windlas Biotech IPO Price, Detail, Opening Date, Allotment Date, Listing Date, Company profile, Owner, BSE, NSE, Lot size, Financial Report, Promoter’s Holdings and More
Windlas Biotech is an Indian company of Pharmaceuticals. The company headquarter is in Uttarakhand, India. The company provides pharmaceutical development services, large-scale manufacturing services and authentic yet affordable products to its customers and consumers around the world.
Windlas Biotech mission is to serve the unmet healthcare needs of society by accelerating drug research of customers, by manufacturing high-quality products and by creating innovative solutions that improve affordability of medicines.
Windlas Biotech established in 2001 by Vivek Dhariwal. The company manufactured authentic nutraceutical, pharmaceutical and ayurvedic products to serve the semi-urban and rural communities at affordable prices.
What is Windlas Biotech IPO?
Windlas Biotech IPO is a main-board IPO of [.] equity shares of the face value of ₹5 aggregating up to ₹401.54 Crores. The issue is priced at ₹448 to ₹460 per equity share. The minimum order quantity is 30 Shares.
The IPO opens on Aug 4, 2021, and closes on Aug 6, 2021.
Windlas Biotech IPO Details
|IPO Opening Date||Aug 4, 2021|
|IPO Closing Date||Aug 6, 2021|
|Issue Type||Book Built Issue IPO|
|IPO Price||₹448 to ₹460 per equity share|
|Market Lot||30 Shares|
|Min Order Quantity||30 Shares|
|Listing At||BSE, NSE|
|Issue Size||[.] Eq Shares of ₹5|
(aggregating up to ₹401.54 Cr)
|Fresh Issue||[.] Eq Shares of ₹5|
(aggregating up to ₹165.00 Cr)
|Offer for Sale||5,142,067 Eq Shares of ₹5|
(aggregating up to ₹236.54 Cr)
|Particulars||For the year/period ended (₹ in million)|
|Profit After Tax||155.70||162.13||638.22|
Windlas Biotech IPO Lot Size
The Windlas Biotech IPO market lot size is 30 shares. A retail-individual investor can apply for up to 14 lots (420 shares or ₹193,200).
Address: 40/1, Mohabewala Industrial Area,
Phone: +91 135 6608000
If you want to know anything else about the Windlas Biotech IPO. Please comment below we will try to provide information.